Auditory and imaging markers of atypical enlarged vestibular aqueduct

xlomafota13 shared this article with you from Inoreader Auditory and imaging markers of atypical enlarged vestibular aqueduct Via http://link.springer.com/journal/405,European archives of oto-rhino-laryngology,The European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino Eur Arch Otorhinolaryngol. 2021 Mar 9. doi: 10.1007/s00405-021-06700-0. Online ahead of print. ABSTRACT PURPOSE: To characterize the auditory and imaging markers of atypical enlarged vestibular aqueduct (EVA). METHODS: 15 EVA cases (26 ears) confirmed via high-resolution MRI (HRMRI) that did not meet the Valvassori criterion on high-resolution CT (HRCT) were classified as atypical EVA. Another 21 EVA cases (40 ears) meeting the Valvassori criterion were randomly chosen as typical EVA. The hearing loss (HL), HRCT, and HRMRI findings were compared between the two groups. RESULTS: The difference of HL severity between atypical and typical EVA was not statistically significant (χ2 = 0.12, P > 0.05. The vestibular aqueducts (VA) of atypical EVA cases manifested as borderline dilation (n = 17), focal dilation (n = 3), and normal appearance (n = 6) on the HRCT. The midpoint width of atypical and typical EVA cases wa s 1.06 ± 0.18 mm and 2.10 ± 0.55 mm, respectively, exhibiting a significant difference (t = - 9.20, P < 0.05). In the HRMRI, the degree of dilation and shape of the intraosseous partition of endolymphatic duct and sac (ES) was similar to that of VA on HRCT, while their extraosseous ES was depicted variable slighter dilation compared to that of typical one, the difference between them was statistically significant (t = - 4.10, P < 0.05). CONCLUSION: The HL severity of atypical EVA ears was similar to that of typical ones. Nevertheless, borderline, focal dilation and normal-like appearance of VAs on HRCT and variablely slighter dilation of the extraosseous ES on HRMRI are its characteristic imaging findings. PMID:33687508 | DOI:10.1007/s00405-021-06700-0 View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.